GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » Dividends Received

Arctic Bioscience AS (OSL:ABS) Dividends Received


View and export this data going back to 2021. Start your Free Trial

What is Arctic Bioscience AS Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.


Arctic Bioscience AS Business Description

Traded in Other Exchanges
Address
Industrivegen 42, Orsta, NOR, 6155
Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company's proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. The company is developing a novel, oral drug candidate (HRO350) for the treatment of mild-to-moderate psoriasis. The company operates geographically in Norway, Americas, Europe, and APAC, with majority of the revenue deriving from Europe.